Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB

Pharmacokinetics and Dosing of Levofloxacin in Children Treated for Active or Latent Multidrug-resistant Tuberculosis, Federated States of Micronesia and Republic of the Marshall Islands

(2016) Sundari R. Mase et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Limited Sampling Strategy and Target Attainment Analysis for Levofloxacin in Patients with Tuberculosis

(2015) Abdullah Alsultan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of macrolides for possible use against multidrug-resistantMycobacterium tuberculosis

(2015) Anne-Fleur van der Paardt et al.   EUROPEAN RESPIRATORY JOURNAL

The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection

(2015) Alper Daskapan et al.   EUROPEAN RESPIRATORY JOURNAL

An interlaboratory quality control programme for the measurement of tuberculosis drugs: TABLE 1

(2015) Rob E. Aarnoutse et al.   EUROPEAN RESPIRATORY JOURNAL

Quantitative Drug-Susceptibility in Patients Treated for Multidrug-Resistant Tuberculosis in Bangladesh: Implications for Regimen Choice

(2015) Scott K. Heysell et al.   PLoS One

Fluoroquinolones for the treatment of tuberculosis in children

(2015) S. Thee et al.   TUBERCULOSIS

Role of therapeutic drug monitoring in pulmonary infections: use and potential for expanded use of dried blood spot samples

(2015) Susan Hofman et al.   Bioanalysis

Pharmacokinetics of Ofloxacin and Levofloxacin for Prevention and Treatment of Multidrug-Resistant Tuberculosis in Children

(2014) S. Thee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Redefining Multidrug-Resistant Tuberculosis Based on Clinical Response to Combination Therapy

(2014) Tawanda Gumbo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Acquired Drug Resistance: We Can Do More Than We Think!

(2014) J.-W. C. Alffenaar et al.   CLINICAL INFECTIOUS DISEASES

Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis

(2014) J. Peter Cegielski et al.   CLINICAL INFECTIOUS DISEASES

Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

(2014) M. L. Bastos et al.   CLINICAL INFECTIOUS DISEASES

Review of Evidence for Measuring Drug Concentrations of First-Line Antitubercular Agents in Adults

(2014) Kyle John Wilby et al.   CLINICAL PHARMACOKINETICS

Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update

(2014) Abdullah Alsultan et al.   DRUGS

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

(2014) C. Lange et al.   EUROPEAN RESPIRATORY JOURNAL

New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects

(2014) Alimuddin I Zumla et al.   LANCET INFECTIOUS DISEASES

Comparison of Levofloxacin versus Moxifloxacin for Multidrug-Resistant Tuberculosis

(2013) Won-Jung Koh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Susceptibility Testing of Extensively Drug-Resistant and Pre-Extensively Drug-Resistant Mycobacterium tuberculosis against Levofloxacin, Linezolid, and Amoxicillin-Clavulanate

(2013) Imran Ahmed et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Plasma Drug Activity in Patients on Treatment for Multidrug-Resistant Tuberculosis

(2013) Stellah G. Mpagama et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis

(2013) N. Alsaad et al.   EUROPEAN RESPIRATORY JOURNAL

Bedaquiline in MDR/XDR-TB cases: first experience on compassionate use

(2013) S. Tiberi et al.   EUROPEAN RESPIRATORY JOURNAL

Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?

(2013) Shashikant Srivastava et al.   EUROPEAN RESPIRATORY JOURNAL

Drug concentration in lung tissue in multidrug-resistant tuberculosis

(2013) Onno W. Akkerman et al.   EUROPEAN RESPIRATORY JOURNAL

In vitro effect of three-drug combinations of antituberculous agents against multidrug-resistant Mycobacterium tuberculosis isolates

(2013) Emma Rey-Jurado et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolones

(2013) Yuri F. van der Heijden et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs

(2013) B. R. Imperiale et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes

(2013) J. G. Pasipanodya et al.   JOURNAL OF INFECTIOUS DISEASES

Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis

(2012) Kristian Ängeby et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Fluoroquinolones, the Cornerstone of Treatment of Drug-Resistant Tuberculosis: A Pharmacokinetic and Pharmacodynamic Approach

(2012) A. D. Pranger et al.   CURRENT PHARMACEUTICAL DESIGN

Microcolonies in fluoroquinolone agar proportion susceptibility testing of Mycobacterium tuberculosis: an indicator of drug resistance

(2012) A. Blackman et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

(2012) Dennis Falzon et al.   EUROPEAN RESPIRATORY JOURNAL

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

(2012) Vija Skripconoka et al.   EUROPEAN RESPIRATORY JOURNAL

gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis

(2012) F. A. Sirgel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin

(2012) E. Y. Nosova et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial

(2012) Rovina Ruslami et al.   LANCET INFECTIOUS DISEASES

Randomized Pharmacokinetic and Pharmacodynamic Comparison of Fluoroquinolones for Tuberculous Meningitis

(2011) Guy E. Thwaites et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience

(2011) A. D. Pranger et al.   EUROPEAN RESPIRATORY JOURNAL

New Susceptibility Breakpoints for First-Line Antituberculosis Drugs Based on Antimicrobial Pharmacokinetic/Pharmacodynamic Science and Population Pharmacokinetic Variability

(2010) T. Gumbo   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data

(2010) K. A. Angeby et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China

(2010) Xiaomao Yin et al.   JOURNAL OF INFECTION

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

(2010) Neel R Gandhi et al.   LANCET

Cerebrospinal fluid concentrations of antituberculosis agents in adults and children

(2010) P.R. Donald   TUBERCULOSIS

Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid and Plasma in Patients with Tuberculous Meningitis

(2009) J. W. C. Alffenaar et al.   CLINICAL INFECTIOUS DISEASES

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis

(2009) Evan W Orenstein et al.   LANCET INFECTIOUS DISEASES

Extensively Drug‐ResistantMycobacterium tuberculosisduring a Trend of Decreasing Drug Resistance from 2000 through 2006 at a Medical Center in Taiwan

(2008) Chih‐Cheng Lai et al.   CLINICAL INFECTIOUS DISEASES